ABSTRACT
The second most significant cause of death in the world is cancer. High mortality occurs in underdeveloped nations due to a lack of adequate and cheap treatments. Many cancer therapies, including surgery, radiation, and chemotherapy, have been explored, but they are all restricted. Nanotechnology may greatly enhance bench-to-clinical treatment systems. Biotechnology has shown the potential of direct evolution in developing industrially significant molecules like nanoparticles and bionanomaterials for over three decades. Bionanomaterials are made up of biological molecules that may be formed into molecular structures of nanoscale dimensions. Bionanomaterials’ tiny size, high surface area, stability, and biocompatibility may allow in situ disease diagnosis. With the increase in cancer incidence, effective clinical diagnostic and therapeutic methods are more important in the early or late stages. Bionanomaterials are used to detect cancer at the molecular level. The development of science and technology and economic affluence has increased people’s concern about health. This chapter’s main aim is to emphasize the role of advanced bionanomaterials in cancer detection and treatment. We will briefly discuss the use of electrochemical nano-bio sensors based on advanced functional nanomaterials for point-of-care diagnostics.
